stem cell therapies (Procella Therapeutics/AstraZeneca)

N/A

Report date: 2025/03/20 09:14:38

Base Information

Drug Namestem cell therapies (Procella Therapeutics/AstraZeneca)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProcella Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcProcella Therapeutics AB
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A